RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$82.4M
2
+$55.9M
3
+$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
+$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$34.8M

Top Sells

1
+$190M
2
+$35.9M
3
+$21M
4
CTMX icon
CytomX Therapeutics
CTMX
+$17.8M
5
WHWK
Whitehawk Therapeutics
WHWK
+$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.02B 17.95%
7,567,900
+180,000
2
$300M 5.29%
2,097,794
3
$206M 3.63%
4,417,259
4
$174M 3.07%
5,614,428
5
$171M 3.02%
8,670,644
6
$157M 2.76%
9,607,028
7
$150M 2.65%
20,241,458
+1,824,000
8
$138M 2.43%
13,150,849
9
$132M 2.33%
5,779,347
10
$132M 2.32%
5,208,911
11
$129M 2.28%
11,120,973
12
$128M 2.26%
9,011,651
13
$102M 1.8%
7,236,454
14
$101M 1.78%
4,240,464
+343,599
15
$98M 1.73%
6,103,594
+160,000
16
$97.4M 1.72%
236,114
17
$86M 1.52%
5,605,129
18
$83.7M 1.48%
4,965,588
19
$83.3M 1.47%
243,540
20
$82.4M 1.45%
+10,230,274
21
$69.7M 1.23%
1,804,795
+204,795
22
$67.3M 1.19%
3,551,508
23
$66.3M 1.17%
2,843,757
-170,200
24
$66M 1.16%
9,770,773
25
$64.9M 1.14%
4,965,769
1
2 3 4 5